医药产业研究周报称,Illumina发布十亿细胞图谱,为三年内构建50亿细胞图谱计划的首批成果,将推进生命科学数据基础设施发展,开启生物学与AI交汇新阶段,包括数据入口龙头转型、构建AI新生态、推动生命科学进入可计算新纪元;监管方面,中国落地eCTD,美国支持贝叶斯方法;全球订单复苏,2026年看好CXO赛道。资本风向方面,GSK22亿美元收购RAPT Therapeutics,天辰生物核心产品...
Source Link医药产业研究周报称,Illumina发布十亿细胞图谱,为三年内构建50亿细胞图谱计划的首批成果,将推进生命科学数据基础设施发展,开启生物学与AI交汇新阶段,包括数据入口龙头转型、构建AI新生态、推动生命科学进入可计算新纪元;监管方面,中国落地eCTD,美国支持贝叶斯方法;全球订单复苏,2026年看好CXO赛道。资本风向方面,GSK22亿美元收购RAPT Therapeutics,天辰生物核心产品...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.